Kidney Cancer Trial, Recruiting NCT04681690 Sponsor: Association of Urologic Oncology (AUO) Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT04681690
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You must be willing and able to sign a consent form agreeing to take part in the trial
  • You must have a localized tumor (mass) on the kidney that can be treated with surgery that aims to save as much of the kidney as possible
  • You must have had a recent detailed scan of your abdomen, either a CT scan or MRI scan, done with contrast dye

Who may not be able to join:

  • You may not be able to join if you have, or are suspected to have, a type of kidney cancer that starts in the lining of the urinary system (called urothelial cancer)
  • You may not be able to join if you have previously had kidney-sparing surgery on the same kidney that is now affected
  • You may not be able to join if your kidney cancer has spread to other parts of the body (metastasized)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nina Harke, Dr., MHH

Phone: 0511/532

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Association of Urologic Oncology (AUO)
Registry
ClinicalTrials.gov
Start date
15 December 2020
Est. completion
15 September 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Complication rate; Postoperative glomerular inflitration rate; Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov